» Articles » PMID: 17372799

Changes in Preferences for Life-sustaining Treatment Among Older Persons with Advanced Illness

Overview
Publisher Springer
Specialty General Medicine
Date 2007 Mar 21
PMID 17372799
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There are conflicting assumptions regarding how patients' preferences for life-sustaining treatment change over the course of serious illness.

Objective: To examine changes in treatment preferences over time.

Design: Longitudinal cohort study with 2-year follow-up.

Participants: Two hundred twenty-six community-dwelling persons age > or =60 years with advanced cancer, congestive heart failure, or chronic obstructive pulmonary disease.

Measurements: Participants were asked, if faced with an illness exacerbation that would be fatal if untreated, whether they would: a) undergo high-burden treatment at a given likelihood of death and b) undergo low-burden treatment at a given likelihood of severe disability, versus a return to current health.

Results: There was little change in the overall proportions of participants who would undergo therapy at a given likelihood of death or disability from first to final interview. Diversity within the population regarding the highest likelihood of death or disability at which the individual would undergo therapy remained substantial over time. Despite a small magnitude of change, the odds of participants' willingness to undergo high-burden therapy at a given likelihood of death and to undergo low-burden therapy at a given likelihood of severe cognitive disability decreased significantly over time. Greater functional disability, poorer quality of life, and lower self-rated life expectancy were associated with decreased willingness to undergo therapy.

Conclusions: Diversity among older persons with advanced illness regarding treatment preferences persists over time. Although the magnitude of change is small, there is a decreased willingness to undergo highly burdensome therapy or to risk severe disability in order to avoid death over time and with declining health status.

Citing Articles

Anticoagulation at the end of life: whether, when, and how to treat.

Parks A Hematology Am Soc Hematol Educ Program. 2024; 2024(1):348-354.

PMID: 39644066 PMC: 11665705. DOI: 10.1182/hematology.2024000559.


Cognitive Trajectories in Older Adults Diagnosed With Hematologic Malignant Neoplasms.

Huang L, Shi Y, Boscardin W, Steinman M JAMA Netw Open. 2024; 7(8):e2431057.

PMID: 39212987 PMC: 11365001. DOI: 10.1001/jamanetworkopen.2024.31057.


Psychosocial Factors Associated With Thoughts Regarding Life-Sustaining Treatment for Oneself and Family Members.

Lee J, Kim S, Lee S, Youn H Psychiatry Investig. 2024; 21(6):646-654.

PMID: 38960442 PMC: 11222083. DOI: 10.30773/pi.2024.0032.


Frailty Assessment Can Enhance Current Risk Prediction Tools in Emergency Laparotomy: A Retrospective Cohort Study.

Isand K, Hussain S, Sadiqi M, Kirsimagi U, Bond-Smith G, Kolk H World J Surg. 2023; 47(11):2688-2697.

PMID: 37589793 DOI: 10.1007/s00268-023-07140-z.


Comparison of different clinical risk scores to predict long-term survival and neurological outcome in adults after cardiac arrest: results from a prospective cohort study.

Blatter R, Amacher S, Bohren C, Becker C, Beck K, Gross S Ann Intensive Care. 2022; 12(1):77.

PMID: 35978065 PMC: 9385915. DOI: 10.1186/s13613-022-01048-y.


References
1.
Pearlman R, Cain K, Patrick D, Starks H, Jecker N, Uhlmann R . Insights pertaining to patient assessments of states worse than death. J Clin Ethics. 1993; 4(1):33-41. View

2.
Dales R, OConnor A, Hebert P, Sullivan K, McKim D, Llewellyn-Thomas H . Intubation and mechanical ventilation for COPD: development of an instrument to elicit patient preferences. Chest. 1999; 116(3):792-800. DOI: 10.1378/chest.116.3.792. View

3.
Borum M, Lynn J, Zhong Z . The effects of patient race on outcomes in seriously ill patients in SUPPORT: an overview of economic impact, medical intervention, and end-of-life decisions. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc. 2000; 48(S1):S194-8. DOI: 10.1111/j.1532-5415.2000.tb03132.x. View

4.
Souchek J, Stacks J, BRODY B, Ashton C, Giesler R, Byrne M . A trial for comparing methods for eliciting treatment preferences from men with advanced prostate cancer: results from the initial visit. Med Care. 2000; 38(10):1040-50. DOI: 10.1097/00005650-200010000-00008. View

5.
Rosenfeld K, Wenger N, Kagawa-Singer M . End-of-life decision making: a qualitative study of elderly individuals. J Gen Intern Med. 2000; 15(9):620-5. PMC: 1495587. DOI: 10.1046/j.1525-1497.2000.06289.x. View